CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)
$5.8001 -0.2749 (-4.5251%)
Analysed CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) News Sources
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
09-04-2026
yahoo.com
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
30-03-2026
yahoo.com
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ...
19-03-2026
yahoo.com
Champions Oncology (CSBR) Earnings Transcript
13-03-2026
fool.com
Champions Oncology, Inc. Q3 2026 Earnings Call Summary
13-03-2026
moby.co
Champions Oncology Reports Revenue of $16.6 Million
12-03-2026
yahoo.com
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
05-03-2026
yahoo.com
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge
20-02-2026
fool.com
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year
20-02-2026
fool.com
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know
20-02-2026
fool.com
What is the current price of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The current price of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is $5.8001.
CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) absolute price change since previous trading day?
The absolute price change of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) since the previous trading day is $-0.2749.
CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) percentage price change since previous trading day?
The percentage price change of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) since the previous trading day is -4.5251%.
What is the most recent average sentiment score for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The most recent average sentiment score for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The most recent sentiment for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is .
SEC-8K** Filing Available For CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.